375 related articles for article (PubMed ID: 2727272)
21. Cataract in atomic bomb survivors based on a threshold model and the occurrence of severe epilation.
Otake M; Neriishi K; Schull WJ
Radiat Res; 1996 Sep; 146(3):339-48. PubMed ID: 8752314
[TBL] [Abstract][Full Text] [Related]
22. Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks.
Little MP; Hawkins MM; Charles MW; Hildreth NG
Radiat Res; 1992 Nov; 132(2):207-21. PubMed ID: 1438703
[TBL] [Abstract][Full Text] [Related]
23. The shape of the cancer mortality dose-response curve for the A-bomb survivors.
Pierce DA; Vaeth M
Radiat Res; 1991 Apr; 126(1):36-42. PubMed ID: 2020737
[TBL] [Abstract][Full Text] [Related]
24. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
Harrison JD; Muirhead CR
Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
[TBL] [Abstract][Full Text] [Related]
25. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
Kellerer AM; Nekolla E
Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
[TBL] [Abstract][Full Text] [Related]
26. Implications of new Hiroshima and Nagasaki dose estimates: cancer risks and neutron RBE.
Straume T; Dobson RL
Health Phys; 1981 Oct; 41(4):666-71. PubMed ID: 7309524
[No Abstract] [Full Text] [Related]
27. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study.
Howe GR; McLaughlin J
Radiat Res; 1996 Jun; 145(6):694-707. PubMed ID: 8643829
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
Little MP
Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
[TBL] [Abstract][Full Text] [Related]
29. [Radiation risks. Results of the new evaluation].
Kellerer AM
Radiologe; 1991 May; 31(5):227-34. PubMed ID: 1876693
[TBL] [Abstract][Full Text] [Related]
30. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment.
Sasaki MS; Nomura T; Ejima Y; Utsumi H; Endo S; Saito I; Itoh T; Hoshi M
Radiat Res; 2008 Jul; 170(1):101-17. PubMed ID: 18582156
[TBL] [Abstract][Full Text] [Related]
31. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
[TBL] [Abstract][Full Text] [Related]
32. [The effects of low radiation doses: carcinogenesis].
Streffer C
Strahlenther Onkol; 1994 Dec; 170(12):681-8. PubMed ID: 7817269
[TBL] [Abstract][Full Text] [Related]
33. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
[TBL] [Abstract][Full Text] [Related]
34. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer risk in mice: analysis of fractionation effects and neutron RBE with a biologically motivated model.
Heidenreich WF; Carnes BA; Paretzke HG
Radiat Res; 2006 Nov; 166(5):794-801. PubMed ID: 17067205
[TBL] [Abstract][Full Text] [Related]
36. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.
Hoshi M; Matsuura M; Hayakawa N; Ito C; Kamada N
Health Phys; 1996 May; 70(5):735-40. PubMed ID: 8690587
[TBL] [Abstract][Full Text] [Related]
37. Leukemia: lessons from the Japanese experience.
Finch SC
Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
[TBL] [Abstract][Full Text] [Related]
38. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
Brenner DJ
Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
[TBL] [Abstract][Full Text] [Related]
39. Analysis of cancer mortality among atomic bomb survivors in Hiroshima Prefecture, 1968-1997.
Zhunussova T; Matsuura M; Hayakawa N
Hiroshima J Med Sci; 2003 Mar; 52(1):1-7. PubMed ID: 12701647
[TBL] [Abstract][Full Text] [Related]
40. Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982.
Preston DL; Kato H; Kopecky K; Fujita S
Radiat Res; 1987 Jul; 111(1):151-78. PubMed ID: 3446217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
